“Dupilumab and Atopic March; Reduction of Incident Allergic Events or Clinical Control?”. Revista Alergia México 71, no. 3 (December 6, 2024): 216–217. Accessed April 30, 2025. https://www.revistaalergia.mx/ojs/index.php/ram/article/view/1302.